A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

NCT04063163 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

585

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer

Interventions

DRUG: HLX10
DRUG: carboplatin and etoposide
DRUG: placebo

Sponsor

Shanghai Henlius Biotech